InvestSMART

Resonance Health Limited (ASX: RHT) - Announcements

- Current share price for RHT : $0.065

ASX company news and announcements for Resonance Health Limited (RHT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Resonance Health Limited (RHT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Resonance Health Limited (RHT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Resonance Health Limited (RHT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$31 Multi Centre testing commences for AI solution 15 Dec 2017 1:45PM $0.025 $0.065 risen by 160%
$31 Change of Director's Interest Notice 11 Dec 2017 5:23PM $0.025 $0.065 risen by 160%
$31 Appendix 3Y Change of Director's Interest Notice 1 Dec 2017 5:46PM $0.024 $0.065 risen by 170.83%
$31 Company Secretary Appointment/Resignation 30 Nov 2017 8:26AM $0.026 $0.065 risen by 150%
$31 Results of Meeting 23 Nov 2017 2:41PM $0.021 $0.065 risen by 209.52%
$31 Change Substantial Shareholder Notification 20 Nov 2017 5:51PM $0.023 $0.065 risen by 182.61%
$31 Appendix 3Y Change of Director's Interest Notice 20 Nov 2017 5:41PM $0.023 $0.065 risen by 182.61%
$31 Appendix 4C - quarterly 31 Oct 2017 6:51PM $0.020 $0.065 risen by 225%
$31 Annual Report to shareholders 23 Oct 2017 12:03PM $0.020 $0.065 risen by 225%
$31 Investor Presentation 19 Oct 2017 8:29AM $0.023 $0.065 risen by 182.61%
$31 Notice of General Meeting/Proxy Form 17 Oct 2017 7:58PM $0.021 $0.065 risen by 209.52%
$31 Collaborative Partnership to develop new AI Diagnostic tools 17 Oct 2017 5:47PM $0.021 $0.065 risen by 209.52%
$31 Beta Testing Success for Cloud-Based A.I. Prototype 17 Oct 2017 4:39PM $0.021 $0.065 risen by 209.52%
$31 Customer Newsletter 2 Oct 2017 7:09PM $0.019 $0.065 risen by 242.11%
$31 Appendix 4G and Corporate Governance Statement 28 Sep 2017 7:03PM $0.021 $0.065 risen by 209.52%
$31 Annual Report 2017 28 Sep 2017 7:02PM $0.021 $0.065 risen by 209.52%
$31 Preliminary Final Report 30 Aug 2017 2:39PM $0.022 $0.065 risen by 195.45%
$31 Beta Testing Commences for Cloud-Based A.I Prototype 21 Aug 2017 12:21AM $0.024 $0.065 risen by 170.83%
$31 Appendix 4C - quarterly 31 Jul 2017 6:48PM $0.025 $0.065 risen by 160%
$31 Equity Research Update Report Released 17 Jul 2017 4:08PM $0.024 $0.065 risen by 170.83%
$31 New Registered Office and Business Address 5 Jul 2017 4:22PM $0.024 $0.065 risen by 170.83%
$31 Final Director's Interest Notice 3 Jul 2017 12:26AM $0.024 $0.065 risen by 170.83%
$31 Customer Newsletter - June 2017 30 Jun 2017 1:53PM $0.024 $0.065 risen by 170.83%
$31 Resignation of Non-Executive Director 29 Jun 2017 12:14AM $0.024 $0.065 risen by 170.83%
$31 Bone Marrow Iron Assessment Launch 22 Jun 2017 12:18AM $0.025 $0.065 risen by 160%

301 - 325 of 532 results

Page 13 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.